Active	Status	Sponsor type	Region	Phase	Filter
9 Active 1 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Johnson, Vanessa
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25
Mocherla, Satish
EBONI, NCT05514509: A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories	Recruiting	4	250	US	APRETUDE, Cabotegravir tablet	ViiV Healthcare	HIV Infections	09/25	09/25
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25
Williams, Katrina
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis	Recruiting	2b	126	US	Phage Therapy, Placebo	Adaptive Phage Therapeutics, Inc., United States Department of Defense	Osteomyelitis, Diabetic Foot Osteomyelitis	04/24	12/24
NCT04821856: Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability	Recruiting	2	140	RoW	Cannabidiol Oil, Placebo	Murdoch Childrens Research Institute, Monash University, University of Sydney, Deakin University	Intellectual Disability, Child Behavior Problem	05/25	06/25
diSArm, NCT05184764: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia	Recruiting	1/2	50	US, RoW	AP-SA02, Placebo	Armata Pharmaceuticals, Inc., United States Department of Defense	Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due to Staphylococcus Aureus	12/24	03/25
NCT04583878: FUVID Study: Functional Characterization of Children with Chronic Venous Thromboembolic Disease	Recruiting	N/A	125	US	Blood draw (Visit 1), Blood draw (Visits 2 and 3)	University of Texas Southwestern Medical Center	Deep Venous Thrombosis, Pulmonary Embolism	12/24	12/24
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25
Pandit, Neha
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25
Mochela, Satish
No trials found